Cite
MLA Citation
Tetsuji Takabayashi et al.. “A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis.” American journal of rhinology & allergy, vol. 35, no. 6, 2021, pp. 861–870. http://access.bl.uk/ark:/81055/vdc_100135266320.0x00001e